Answers are grounded in this paper and cite their sources.
Fusarium head blight (FHB) is a devastating global disease of wheat caused by a diverse range of Fusarium species. Among these pathogens, Fusarium kyushuense is an important causal agent that poses a persistent threat to wheat production and grain safety in specific geographic regions. Fludioxonil is a phenylpyrrole fungicide registered for FHB control in China. In this study, a F. kyushuense strain exhibiting high-level resistance to fludioxonil was found to harbor a Y505C substitution within the kinase domain of FkPbs2. Genetic validation confirmed that the FkPbs2 Y505C substitution is the primary determinant of fludioxonil resistance in F. kyushuense . Biochemical assays showed that the FkPbs2 Y505C mutation significantly reduces FkHog1 phosphorylation and impairs intracellular glycerol accumulation under both fludioxonil exposure and osmotic stress conditions. This compromised signaling response prevents lethal hyperactivation of the HOG-MAPK pathway and alleviates subsequent cytotoxic effects. Furthermore, the FkPbs2 Y505C allele imposes substantial fitness costs, including reduced conidiation, lower germination rates, and decreased virulence on wheat spikes and coleoptiles. Resistant strains also exhibited hypersensitivity to osmotic stress, suggesting reduced competitive ability in natural environments. No cross-resistance was observed between fludioxonil and tebuconazole, carbendazim, phenamacril, pyraclostrobin, or pydiflumetofen. Collectively, these findings demonstrate that FkPbs2 Y505C confers fludioxonil resistance and provide a theoretical foundation for resistance risk assessment and sustainable management of FHB.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: